Abstract
BackgroundThe 12-lead electrocardiographic screening for the prevention of sudden cardiac death in young competitive athletes is not cost-effective and thus not routinely recommended. We investigate whether a less expensive wireless electrocardiographic transmission device can be used to screen for the prevention of sudden cardiac death in this population.MethodsDuring pre-participation screening, twenty college football players underwent two electrocardiograms: a conventional 12-lead electrocardiogram and a wireless 9-lead electrocardiogram. We compared several electrocardiographic parameters (QRS duration, left ventricular hypertrophy using the Cornell voltage criteria and the Sokolow–Lyon criteria, ST deviation and corrected QT interval) to determine the correlation.ResultsThe QRS duration, left ventricular hypertrophy using the Cornell voltage criteria and the Sokolow–Lyon criteria and corrected QT interval exhibited significant correlation between the two types of electrocardiograms (correlation coefficient 0.878, 0.630, 0.770 and 0.847, respectively with P values of 0.01, 0.003, 0.01 and 0.01, respectively). ST deviation in V1 was weakly correlated between the two types of electrocardiograms without statistical significance (correlation coefficient 0.360 with a P value of 0.119).ConclusionsOur newly developed wireless 9-lead electrocardiogram demonstrated significant correlations with a conventional 12-lead electrocardiogram in terms of QRS duration, left ventricular hypertrophy and corrected QT interval.
Highlights
The 12-lead electrocardiographic screening for the prevention of sudden cardiac death in young competitive athletes is not cost-effective and not routinely recommended
The 12-lead electrocardiogram (ECG) for the screening of sudden cardiac death in young competitive athletes is recommended by the European Society of Cardiology (ESC), but not by the American Heart Association (AHA) and American College of Cardiology (ACC) [4, 5]
The ESC recommended mandatory 12-lead ECG for sudden cardiac death screening in young competitive athletes based on the Italian study conducted by Corrado et al [6], which showed a 79 % relative risk reduction
Summary
The 12-lead electrocardiographic screening for the prevention of sudden cardiac death in young competitive athletes is not cost-effective and not routinely recommended. In the United States, the most common cause of sudden cardiac death among athletes has been reported as hypertrophic cardiomyopathy (26.4 %) [2]. An observational study in Italy showed that sudden cardiac death in. The 12-lead electrocardiogram (ECG) for the screening of sudden cardiac death in young competitive athletes is recommended by the European Society of Cardiology (ESC), but not by the American Heart Association (AHA) and American College of Cardiology (ACC) [4, 5]. The ESC recommended mandatory 12-lead ECG for sudden cardiac death screening in young competitive athletes based on the Italian study conducted by Corrado et al [6], which showed a 79 % relative risk reduction. A cost-projection model showed that the cost per life saved would be between 10.6 and 14.4 million Dollars in the United States [7]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
